A preliminary study of telemedicine for patients with hepatic glycogen storage disease and their healthcare providers : from bedside to home site monitoring
(2018) In Journal of Inherited Metabolic Disease 41(6). p.929-936- Abstract
Background: The purpose of this project was to develop a telemedicine platform that supports home site monitoring and integrates biochemical, physiological, and dietary parameters for individual patients with hepatic glycogen storage disease (GSD). Methods and results: The GSD communication platform (GCP) was designed with input from software developers, GSD patients, researchers, and healthcare providers. In phase 1, prototyping and software design of the GCP has occurred. The GCP was composed of a GSD App for patients and a GSD clinical dashboard for healthcare providers. In phase 2, the GCP was tested by retrospective patient data entry. The following software functionalities were included (a) dietary registration and prescription... (More)
Background: The purpose of this project was to develop a telemedicine platform that supports home site monitoring and integrates biochemical, physiological, and dietary parameters for individual patients with hepatic glycogen storage disease (GSD). Methods and results: The GSD communication platform (GCP) was designed with input from software developers, GSD patients, researchers, and healthcare providers. In phase 1, prototyping and software design of the GCP has occurred. The GCP was composed of a GSD App for patients and a GSD clinical dashboard for healthcare providers. In phase 2, the GCP was tested by retrospective patient data entry. The following software functionalities were included (a) dietary registration and prescription module, (b) emergency protocol module, and (c) data import functions for continuous glucose monitor devices and activity wearables. In phase 3, the GSD App was implemented in a pilot study of eight patients with GSD Ia (n = 3), GSD IIIa (n = 1), and GSD IX (n = 4). Usability was measured by the system usability scale (SUS). The mean SUS score was 64/100 [range: 38–93]. Conclusions: This report describes the design, development, and validation process of a telemedicine platform for patients with hepatic GSD. The GCP can facilitate home site monitoring and data exchange between patients with hepatic GSD and healthcare providers under varying circumstances. In the future, the GCP may support cross-border healthcare, second opinion processes and clinical trials, and could possibly also be adapted for other diseases for which a medical diet is the cornerstone.
(Less)
- author
- Hoogeveen, Irene J. ; Peeks, Fabian ; de Boer, Foekje ; Lubout, Charlotte M.A. ; de Koning, Tom J. LU ; te Boekhorst, Sebastiaan ; Zandvoort, Robert Jan ; Burghard, Rob ; van Spronsen, Francjan J. and Derks, Terry G.J.
- publishing date
- 2018-12
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Dietary management, Hepatic glycogen storage diseases, Mobile application, Monitoring, Rare diseases, Telemedicine
- in
- Journal of Inherited Metabolic Disease
- volume
- 41
- issue
- 6
- pages
- 929 - 936
- publisher
- Springer
- external identifiers
-
- pmid:29600495
- scopus:85044517750
- ISSN
- 0141-8955
- DOI
- 10.1007/s10545-018-0167-2
- language
- English
- LU publication?
- no
- id
- 3fec5eae-2177-4f35-acd9-4d2b4dac2eaa
- date added to LUP
- 2020-02-11 12:41:05
- date last changed
- 2024-05-30 11:54:26
@article{3fec5eae-2177-4f35-acd9-4d2b4dac2eaa,
abstract = {{<p>Background: The purpose of this project was to develop a telemedicine platform that supports home site monitoring and integrates biochemical, physiological, and dietary parameters for individual patients with hepatic glycogen storage disease (GSD). Methods and results: The GSD communication platform (GCP) was designed with input from software developers, GSD patients, researchers, and healthcare providers. In phase 1, prototyping and software design of the GCP has occurred. The GCP was composed of a GSD App for patients and a GSD clinical dashboard for healthcare providers. In phase 2, the GCP was tested by retrospective patient data entry. The following software functionalities were included (a) dietary registration and prescription module, (b) emergency protocol module, and (c) data import functions for continuous glucose monitor devices and activity wearables. In phase 3, the GSD App was implemented in a pilot study of eight patients with GSD Ia (n = 3), GSD IIIa (n = 1), and GSD IX (n = 4). Usability was measured by the system usability scale (SUS). The mean SUS score was 64/100 [range: 38–93]. Conclusions: This report describes the design, development, and validation process of a telemedicine platform for patients with hepatic GSD. The GCP can facilitate home site monitoring and data exchange between patients with hepatic GSD and healthcare providers under varying circumstances. In the future, the GCP may support cross-border healthcare, second opinion processes and clinical trials, and could possibly also be adapted for other diseases for which a medical diet is the cornerstone.</p>}},
author = {{Hoogeveen, Irene J. and Peeks, Fabian and de Boer, Foekje and Lubout, Charlotte M.A. and de Koning, Tom J. and te Boekhorst, Sebastiaan and Zandvoort, Robert Jan and Burghard, Rob and van Spronsen, Francjan J. and Derks, Terry G.J.}},
issn = {{0141-8955}},
keywords = {{Dietary management; Hepatic glycogen storage diseases; Mobile application; Monitoring; Rare diseases; Telemedicine}},
language = {{eng}},
number = {{6}},
pages = {{929--936}},
publisher = {{Springer}},
series = {{Journal of Inherited Metabolic Disease}},
title = {{A preliminary study of telemedicine for patients with hepatic glycogen storage disease and their healthcare providers : from bedside to home site monitoring}},
url = {{http://dx.doi.org/10.1007/s10545-018-0167-2}},
doi = {{10.1007/s10545-018-0167-2}},
volume = {{41}},
year = {{2018}},
}